Forecasting The Future: 7 Analyst Projections For Novo Nordisk
Media

Forecasting The Future: 7 Analyst Projections For Novo Nordisk

Latest Ratings for NVO

Date Firm Action From To
Jan 2022 Liberum Downgrades Hold Sell
Dec 2021 JP Morgan Downgrades Overweight Neutral
Jan 2021 Deutsche Bank Initiates Coverage On Buy

View More Analyst Ratings for NVO

View the Latest Analyst Ratings

read more

​ 

​Latest Ratings for NVO
DateFirmActionFromTo Jan 2022LiberumDowngradesHoldSell Dec 2021JP MorganDowngradesOverweightNeutral Jan 2021Deutsche BankInitiates Coverage OnBuy
View More Analyst Ratings for NVO

View the Latest Analyst Ratings

read more 

This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.